首页> 外国专利> SIMULATION MODEL OF TYPE 1 DIABETIC PATIENT DECISION-MAKING

SIMULATION MODEL OF TYPE 1 DIABETIC PATIENT DECISION-MAKING

机译:1型糖尿病患者决策的模拟模型

摘要

A mathematical model of type 1 diabetes (T1D) patient decision-making can be used to simulate, in silico, realistic glucose/insulin dynamics, for several days, in a variety of subjects who take therapeutic actions (e.g. insulin dosing) driven by either self-monitoring blood glucose (SMBG) or continuous glucose monitoring (CGM). The decision-making (DM) model can simulate real-life situations and everyday patient behaviors, Accurate submodels of SMBG and CGM measurement errors are incorporated in the comprehensive DM model. The DM model accounts for common errors the patients are used to doing in their diabetes management, such as miscalculations of meal carbohydrate content, early/delayed insulin administrations and missed insulin boluses. The DM model can be used to assess in silico if/when CGM can safely substitute SMBG in T1D management, to develop and test guidelines for CGM driven insulin dosing, to optimize and individualize off-line insulin therapies and to develop and test decision support systems.
机译:1型糖尿病(T1D)患者决策的数学模型可用于模拟在数日内在受以下任一因素驱动而采取治疗行动(例如胰岛素剂量)的各种受试者中的真实葡萄糖/胰岛素动态自我监测血糖(SMBG)或连续血糖监测(CGM)。决策(DM)模型可以模拟现实情况和患者的日常行为,全面的DM模型中包含了SMBG和CGM测量误差的准确子模型。 DM模型解释了患者在糖尿病管理中常犯的常见错误,例如,膳食碳水化合物含量的计算错误,早期/延迟的胰岛素给药以及漏服的胰岛素。 DM模型可用于评估CGM是否可以在T1D管理中安全替代SMBG时进行计算机评估,以开发和测试CGM驱动的胰岛素剂量指南,优化和个性化离线胰岛素疗法,以及开发和测试决策支持系统。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号